We are delighted to add our latest Educational Series on an exciting and developing area of medicine: RNA therapies in cardiovascular medicine.
This review focuses on RNA therapies that work to silence genes in cardiovascular medicine through the use of single-stranded antisense oligonucleotides and double-stranded small interfering molecules that operate through RNA interference.
The review includes guiding commentary from two leading experts, Associate Professor John Amerena and Clinical Associate Professor David Sullivan.
Please login below to download this issue (PDF)